Medplus Health Services Ltd Stock Price Today (NSE: MEDPLUS)
Fundamental Score
Medplus Health Services Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Medplus Health Services Ltd share price today is ₹839.90, down 0.78% on NSE/BSE as of 30 March 2026. Medplus Health Services Ltd (MEDPLUS) is a Mid-cap company in the Pharmacy Retail sector with a market capitalisation of ₹9.71K (Cr). The 52-week high for MEDPLUS share price is ₹1045.30 and the 52-week low is ₹678.05. At a P/E ratio of 49.79x, MEDPLUS is currently trading above its industry average P/E of 45.55x. The company has a Return on Equity (ROE) of 8.80% and a debt-to-equity ratio of 0.65.
Medplus Health Services Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Medplus Health Services Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Medplus Health Services Share Price: A Financial Stability Analysis
A key trend shaping the pharmacy retail sector is the increasing consolidation of independent pharmacies under larger, organized chains. This analysis examines the financial stability of Medplus Health Services Ltd, focusing on factors impacting its long-term viability. Currently, the Medplus Health Services share price stands at ₹868.900024. This analysis forms part of a broader, 80-parameter fundamental audit, verified by Sweta Mishra, designed to provide a comprehensive assessment of the company's financial health.
The company's Price-to-Earnings (PE) ratio is a significant indicator. At 49.79, the PE suggests that the market has high expectations for future earnings growth. The sustainability of this valuation hinges on Medplus's ability to maintain and accelerate its growth trajectory. Evaluating management's ability to execute its growth strategy is crucial. In contrast to
Entero Healthcare Solutions, an assessment of Medplus's management team's track record in efficiently managing expansion and maintaining profitability will provide valuable insights into its future performance.Return on Capital Employed (ROCE) is a critical metric for evaluating profitability and capital efficiency. Medplus Health Services Ltd boasts a ROCE of 10.28%. While positive, the impact of this ROCE on the company's economic moat requires deeper examination. A higher ROCE, consistently maintained, suggests a stronger competitive advantage, as it indicates the company's ability to generate higher returns on its invested capital than its competitors. A consistent and improving ROCE would suggest a widening moat, whereas a declining ROCE could indicate eroding competitive advantages.
In conclusion, this assessment of Medplus Health Services Ltd. considers the current share price in relation to key financial ratios and industry dynamics. The high PE ratio suggests investor optimism, while the ROCE provides a baseline for evaluating capital efficiency and moat strength. Further analysis, encompassing a wider range of financial metrics and qualitative factors, is necessary for a complete picture of the company's financial stability.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Medplus Health Services Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of MEDPLUS across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Robust Profit Growth (43.26%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Consistent Growth Track Record (16.41% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (131.42% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Strong Cash Generation (₹469.03 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Strong Institutional Confidence (FII+DII: 43.04%)
Observation: Significant professional investor participation.
Analysis: High institutional holding often signals thorough due diligence.
Risk Factors
5 factors identified
Below-Average Return on Equity (8.80%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Premium Valuation Risk (P/E: 49.79x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Weak Earnings Growth (-35.35% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
High Share Pledging Risk (59.34%)
Observation: Significant promoter share pledging creates potential overhang.
Analysis: High pledging levels may create selling pressure during market downturns.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Medplus Health Services Ltd Financial Statements
Comprehensive financial data for Medplus Health Services Ltd including income statement, balance sheet and cash flow
About MEDPLUS (Medplus Health Services Ltd)
Medplus Health Services Ltd is a ubiquitous presence in the Indian pharmacy retail landscape, distinguished by its extensive network of strategically located stores. More than just... a place to purchase medication, Medplus offers a comprehensive healthcare destination. Shelves are stocked with an array of pharmaceuticals, ranging from essential prescription drugs to readily available over-the-counter remedies. Beyond traditional medicines, Medplus caters to a growing health-conscious consumer base by providing a wide selection of wellness products, including vitamins, nutritional supplements, and medical devices designed for home use. This commitment to diverse product offerings positions Medplus as a one-stop shop for individuals seeking both curative and preventative healthcare solutions. The reach of Medplus extends beyond prescription fulfillment and over-the-counter sales. The company has diversified its offerings to include fast-moving consumer goods, recognizing the convenience and value of integrating everyday household essentials into its retail environment. Customers can find a variety of personal care items, such as toiletries, soaps, and sanitizers, alongside baby care products and cleaning supplies. This strategic inclusion of FMCG items enhances the shopping experience, making Medplus a convenient location for customers to address multiple needs in a single trip. The company's commitment to quality and value ensures that customers have access to reliable and affordable products across all categories. Beyond its retail presence, Medplus operates a wholesale division, catering to smaller pharmacies and healthcare providers through a cash-and-carry model. This business segment contributes to the broader accessibility of pharmaceuticals and healthcare products across the Indian market. In addition to product sales, Medplus also offers diagnostic services, further solidifying its position as a comprehensive healthcare provider. This multifaceted approach, encompassing retail, wholesale, and diagnostic services, sets Medplus apart in the competitive pharmacy retail sector, offering a holistic approach to meeting the diverse healthcare needs of its customers.
Company Details
Key Leadership
MEDPLUS Share Price: Frequently Asked Questions
What is the current share price of Medplus Health Services Ltd (MEDPLUS)?
As of 30 Mar 2026, 12:07 pm IST, Medplus Health Services Ltd share price is ₹839.90. The MEDPLUS stock has a market capitalisation of ₹9.71K (Cr) on NSE/BSE.
Is MEDPLUS share price Overvalued or Undervalued?
MEDPLUS share price is currently trading at a P/E ratio of 49.79x, compared to the industry average of 45.55x. Based on this relative valuation, the Medplus Health Services Ltd stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of MEDPLUS share price?
The 52-week high of MEDPLUS share price is ₹1045.30 and the 52-week low is ₹678.05. These values are updated daily from NSE/BSE price data.
What factors affect the Medplus Health Services Ltd share price?
Key factors influencing MEDPLUS share price include quarterly earnings growth (Sales Growth: 6.54%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Medplus Health Services Ltd a good stock for long-term investment?
Medplus Health Services Ltd shows a 5-year Profit Growth of 131.42% and an ROE of 8.80%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.65 before investing in MEDPLUS shares.
How does Medplus Health Services Ltd compare with its industry peers?
Medplus Health Services Ltd competes with major peers in the Pharmacy Retail. Investors should compare MEDPLUS share price P/E of 49.79x and ROE of 8.80% against the industry averages to determine competitive standing.
What is the P/E ratio of MEDPLUS and what does it mean?
MEDPLUS share price has a P/E ratio of 49.79x compared to the industry average of 45.55x. Investors pay ₹50 for every ₹1 of annual earnings.
How is MEDPLUS performing according to Bull Run's analysis?
MEDPLUS has a Bull Run fundamental score of 30.9/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does MEDPLUS belong to?
MEDPLUS operates in the Pharmacy Retail industry. This classification helps understand the competitive landscape and sector-specific trends affecting Medplus Health Services Ltd share price.
What is Return on Equity (ROE) and why is it important for MEDPLUS?
MEDPLUS has an ROE of 8.80%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Medplus Health Services Ltd generates profits from shareholders capital.
How is MEDPLUS debt-to-equity ratio and what does it indicate?
MEDPLUS has a debt-to-equity ratio of 0.65, which indicates moderate leverage that should be monitored.
What is MEDPLUS dividend yield and is it a good dividend stock?
MEDPLUS offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Medplus Health Services Ltd shares.
How has MEDPLUS share price grown over the past 5 years?
MEDPLUS has achieved 5-year growth rates of: Sales Growth 16.41%, Profit Growth 131.42%, and EPS Growth -35.35%.
What is the promoter holding in MEDPLUS and why does it matter?
Promoters hold 40.29% of MEDPLUS shares, with 59.34% pledged. High promoter holding often indicates strong management confidence in Medplus Health Services Ltd.
What is MEDPLUS market capitalisation category?
MEDPLUS has a market capitalisation of ₹9713 crores, placing it in the Mid-cap category.
How volatile is MEDPLUS stock?
MEDPLUS has a beta of N/A. A beta > 1 suggests the Medplus Health Services Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is MEDPLUS operating profit margin trend?
MEDPLUS has a 5-year average Operating Profit Margin (OPM) of 6.90%, indicating the company's operational efficiency.
How is MEDPLUS quarterly performance?
Recent quarterly performance shows Medplus Health Services Ltd YoY Sales Growth of 6.54% and YoY Profit Growth of 43.26%.
What is the institutional holding pattern in MEDPLUS?
MEDPLUS has FII holding of 16.53% and DII holding of 26.51%. Significant institutional holding often suggests professional confidence in the Medplus Health Services Ltd stock.